BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22898284)

  • 1. [Association between platelet-activating factor acetylhydrolase gene polymorphism and intracranial hemorrhage in preterm infants].
    Zhang Q; Cheng XR; Xu SL; Shi ZY; Sheng GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Aug; 14(8):612-5. PubMed ID: 22898284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between platelet-activating factor acetylhydrolase gene polymorphisms and gastrointestinal bleeding in children with Henoch-Schönlein purpura].
    Wang BX; Mei H; Peng HM; Gao Y; Ding Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):385-388. PubMed ID: 28407821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between desmin gene, platelet-activating factor acetylhydrolase gene and dilated cardiomyopathy].
    Wang B; Rao L; Zhang L; Zhou B; Wang YP; Chen XY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 May; 37(3):391-4. PubMed ID: 16761416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in plasma platelet-activating factor acetylhydrolase is involved in resistance to immunoglobulin treatment in Kawasaki disease.
    Minami T; Suzuki H; Takeuchi T; Uemura S; Sugatani J; Yoshikawa N
    J Pediatr; 2005 Jul; 147(1):78-83. PubMed ID: 16027700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
    Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
    J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the G994T and R92H genotypes of platelet-activating factor acetylhydrolase with risk of preeclampsia in Chinese women.
    Zhou M; Chen M; Bai H; He GL; Liu QQ; Guan LB; Liu XH; Fan P
    Pregnancy Hypertens; 2020 Apr; 20():19-26. PubMed ID: 32145524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of 994(G--> T) mutation in the plasma platelet-activating factor acetylhydrolase gene in the patients with cerebral infarction].
    Zhang X; Yuan CL; Zhang HZ; Xu J; Wu J; Chen BL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):450-2. PubMed ID: 16086290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma platelet-activating factor acetylhydrolase (PAF-AH) deficiency as a risk factor for stroke].
    Satoh K
    Brain Nerve; 2008 Nov; 60(11):1319-24. PubMed ID: 19069165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype.
    Li S; Stuart L; Zhang Y; Meduri GU; Umberger R; Yates CR
    J Clin Pharm Ther; 2009 Aug; 34(4):447-55. PubMed ID: 19583678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma platelet-activating factor-acetyl hydrolase activity and the levels of free forms of biomarker of lipid peroxidation in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.
    Hirashima Y; Doshi M; Hayashi N; Endo S; Akazawa Y; Shichiri M; Yoshida Y
    Neurosurgery; 2012 Mar; 70(3):602-9. PubMed ID: 21866060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the G994T polymorphism in exon 9 of plasma platelet-activating factor acetylhydrolase gene as a risk factor for polycystic ovary syndrome.
    Fan P; Liu HW; Wang XS; Zhang F; Song Q; Li Q; Wu HM; Bai H
    Hum Reprod; 2010 May; 25(5):1288-94. PubMed ID: 20185515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor-acetylhydrolase A379V (exon 11) gene polymorphism is an independent and functional risk factor for premature myocardial infarction.
    Liu PY; Li YH; Wu HL; Chao TH; Tsai LM; Lin LJ; Shi GY; Chen JH
    J Thromb Haemost; 2006 May; 4(5):1023-8. PubMed ID: 16689754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the Val34Leu polymorphism in the factor XIII gene in infants with a birth weight below 1500 g.
    Göpel W; Kattner E; Seidenberg J; Kohlmann T; Segerer H; Möller J;
    J Pediatr; 2002 Jun; 140(6):688-92. PubMed ID: 12072871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifications of plasma platelet-activating factor (PAF)-acetylhydrolase/PAF system activity in patients with chronic hepatitis C virus infection.
    Caini P; Guerra CT; Giannini C; Giannelli F; Gragnani L; Petrarca A; Solazzo V; Monti M; Laffi G; Zignego AL
    J Viral Hepat; 2007 Jan; 14(1):22-8. PubMed ID: 17212640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Ala379Val polymorphism of platelet-activating factor acetylhydrolase gene in Chinese patients with pre-eclampsia].
    Su LH; Liu XH; He GL; Gao Q; Bai H; Fan P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jan; 46(1):108-12. PubMed ID: 25807807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticles.
    Mitsios JV; Vini MP; Stengel D; Ninio E; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1907-13. PubMed ID: 16728656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
    Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
    Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in plasma platelet-activating factor acetylhydrolase (Val279Phe) is a genetic risk factor for cerebral hemorrhage but not for hypertension.
    Yoshida H; Imaizumi T; Fujimoto K; Itaya H; Hiramoto M; Yoshimizu N; Fukushi K; Satoh K
    Thromb Haemost; 1998 Sep; 80(3):372-5. PubMed ID: 9759612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.